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Skeletal muscle resistance to insulin is related to accumulation of lipid-derived products, but
it is not clear whether this accumulation is caused by skeletal muscle mitochondrial dysfunc-
tion. Diabetes and obesity are reported to have a selective effect on the function of subsar-
colemmal and interfibrillar mitochondria in insulin-resistant skeletal muscle. The current
study investigated the role of the subpopulations of mitochondria in the pathogenesis of
insulin resistance in the absence of obesity. A non-obese spontaneous rat model of type 2
diabetes mellitus, (Goto-Kakizaki), was used to evaluate function and biochemical proper-
ties in both populations of skeletal muscle mitochondria. In subsarcolemmal mitochondria,
minor defects are observed whereas in interfibrillar mitochondria function is preserved. Sub-
sarcolemmal mitochondria defects characterized by a mild decline of oxidative phosphoryla-
tion efficiency are related to ATP synthase and structural alterations of inner mitochondria
membrane but are considered unimportant because of the absence of defects upstream as
shown with polarographic and spectrophometric assays. Fatty acid transport and oxidation
is preserved in both population of mitochondria, whereas palmitoyl-CoA increased 25% in
interfibrillar mitochondria of diabetic rats. Contrary to popular belief, these data provide com-
pelling evidence that mitochondrial function is unaffected in insulin-resistant skeletal muscle
from T2DM non-obese rats.
Introduction
Muscle metabolic function, vital in maintaining health and quality of life, declines in type 2
diabetes mellitus (T2DM), accompanied by mitochondrial dysfunction and insulin resistance
(IR). Skeletal muscle IR plays a major role in the pathogenesis of T2DM, because, during
the postprandial state, 65–80% of whole body glucose uptake takes place in skeletal muscle
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stimulated by insulin [1]. Resistance of skeletal muscle to insulin is related to an accumulation
of lipids, which appears to impair the insulin signaling pathway [2] that triggers glucose uptake
in the muscle. The cause of the accumulated lipid-derived products (or lipid derivatives) is less
clear and there still is a debate as to whether skeletal muscle mitochondria have a primary or
secondary role in this accumulation [3,4].
Both human and animal model studies provide conflicting results concerning the primary
or secondary role of skeletal muscle mitochondria in determining IR [5,6]. It is not clear
whether lipid accumulation is caused by mitochondrial dysfunction rather than by enhanced
fatty acid transport and/or overload [4, 7, 8]. T2DM is typically associated with obesity; skeletal
muscle mitochondrial function, electron transport chain (ETC) activity, fatty acid transport,
and β-oxidation function have been investigated under IR and obese conditions [6, 9, 10].
These investigations have been extended to lean and obese conditions without IR to determine
the causal relationship between IR, fat overload, and mitochondria energy metabolism during
the progression of the disease [11, 12, 13].
In obese T2DM patients, bioenergetics studies on permeabilized skeletal muscle fibers [5,
14] showed lower respiration rate than that measured in the control group. But respiration
rate normalized to citrate synthase as a biomarker of mitochondria content was similar in dia-
betic and control subjects. In contrast to the view of normal mitochondria function, another
study [6] reported reduced complex I activity in skeletal muscle mitochondria isolated from
frozen biopsies from obese T2DM patients. In obese nondiabetic subjects, palmitate oxidation
was reduced in muscle strips [9] while not altered in isolated mitochondria [12]. In the former
study, citrate synthase was not measured while in the second study citrate synthase was
reduced in muscle of obese women [12]. This difference could be attributed to the reduced
mitochondrial content within the muscle strip as reported for the permeabilized fibers studies
on diabetic patients [5, 14]. Another skeletal muscle mitochondria study also reported similar
palmitoylcarnitine oxidation in obese nondiabetic and T2DM patients [10]. Consistent with
the notion of a decreased mitochondrial content in muscle of obese patients, a study on leg
substrate oxidation using arteriovenous measurements, observed a reduced capacity to oxidize
fatty acid in obese subjects [6]. In the latter study, muscle carnitine palmitoyltransferase
(CPT1) activity was reduced in obese individuals. CPT1 is a mitochondrial enzyme that cata-
lyzes the conversion of fatty acyl-CoA to acylcarnitine, which can be transported into mito-
chondria for β-oxidation. In lean insulin-resistant individuals, alteration of skeletal muscle
metabolism involved a 30% decrease in muscle substrate oxidation in the presence of elevated
intramyocyte lipid and plasma fatty acid concentrations [11].
A high fat diet animal study using skeletal muscle and isolated mitochondria suggested that
mitochondria fatty acid oxidation was increased in the insulin-resistant rodent [15]. Moreover,
in a similar study, an increase of incomplete fatty acid oxidation was found to contribute to
skeletal muscle insulin resistance [16]. Also, a high fat diet was reported to increase mitochon-
dria proton leak and capacity to oxidize fatty acid although this capacity was not increased in
skeletal muscle [17]. The accumulation of fatty acid oxidation intermediates appears to cause
mitochondrial uncoupling with ATP production inefficiency.
Skeletal muscle mitochondria exist in at least two populations, subsarcolemmal (SSM) and
interfibrillar (IFM); diabetes and obesity have been reported to selectively affect SSM rather
than IFM in determining alterations of bioenergetic function. In a human study, the relative
succinate oxidase activity was selectively reduced in SSM rather than in IFM of skeletal muscle
of obese and T2DM populations [18]. In the same study, electron transport chain (ETC) activ-
ity of SSM was reduced in diabetic patients compared to active lean adults. In obese Zucker rat
skeletal muscle, fatty acid transport, esterification, and oxidation were enhanced in SSM, but
unaltered in IFM [19]. In contrast, another study reported that the respiratory capacity of SSM
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was reduced and that of IFM was preserved in skeletal muscle of rats fed a high fat diet [13].
Thus, the cause for the discrepancies between human and animal model studies is not
resolved. The role of the subpopulations of mitochondria in the pathogenesis of IR in the
absence of obesity has not been dealt with. Therefore, in this study, a non-obese and spontane-
ous rat model of T2DM, Goto-Kakizaki (GK), was used to evaluate bioenergetic function in
both populations measuring integrated mitochondria function, as well as β-oxidation and
ETC activity. Our proposal was that in the absence of obesity in insulin-resistant rats, bioener-
getic function and biochemical properties of the ETC as well as fat oxidation are not altered in
skeletal muscle mitochondria, both SSM and IFM.
Methods
Materials
Reagents: Dispase, trypsin and collagenase type 2 were purchased from Worthington Bio-
chemical Corporation (Lakewood, NJ. Unless otherwise specified, all other reagents were
obtained from Sigma-Aldrich (St Louis, MO, USA).
Buffers
The buffers, Chappell–Perry (CP) (100 mM KCl, 50 mM MOPS, 5 mM MgSO4, 1mM ATP)
[20], CP2 (Buffer CP plus 0.2% defatted BSA and 1 mM EGTA), KME (100 mM KCl, 50 mM
MOPS and 0.5 mM EGTA, pH 7.4) were prepared for tissue storage, mitochondrial isolation,
and mitochondria storage [21]. The respiration buffer (80 mM KCl, 50 mM MOPS, 1 mM
EGTA, 5 mM KH2PO4, and 1 mg/mL defatted BSA, pH 7.0) was used for mitochondrial oxy-
gen uptake measurements [22].
Animal model
The experimental protocols conformed to the Guide for the Care and Use of Laboratory Ani-
mals published by the National Research Council [23] and were approved by the Case Western
Reserve University Institutional Animal Care and Use Committee. A non-obese model of type
2 diabetes mellitus (T2DM), Goto-Kakizaki (GK) rats, and Wistar colony rats as a control
group were obtained from Charles River. Twelve male GK and 12 male Wistar (W) rats were
housed in pairs in the Animal Resource Center facilities of Case Western Reserve University
under a 12:12-h light-dark cycle and were fed a standard diet chow (Prolab Isopro RMH 3000,
LabDiet, St. Louis, MO). The GK and W rats were euthanized by decapitation using a guillo-
tine at 18 wk (n = 6) and 28 wk (n = 6) of age.
Isolation of mitochondria
Skeletal muscle SSM and IFM were isolated from quadriceps muscle (2–4 g wet tissue) using a
previously developed [24, 25] protocol with minor modifications. After fat and connective tis-
sue were removed, the skeletal muscle was blotted dry and weighed. To separate fibers, the tis-
sue was minced and resuspended in cold (4˚C) buffer (CP) (5 ml/ g wet tissue), and incubated
with 0.18 mg dispase per gram wet tissue in CP buffer with stirring on ice for 10 min. Subse-
quently, 10 ml of CP2 buffer/g wet tissue was added to the sample and centrifuged at 7650g for
10 min. The pellet was resuspended in CP2 buffer (5 ml/ g wet tissue) and homogenized at 400
rpm (Fisher Maxima Overhead Stirrer) with a loose pestle (Potter-Elvehjem) and centrifuged
for 10 min at 580 g. The supernatant was decanted from the myofibrillar pellet and centrifuged
at 7000 g for 20 min to collect the SSM fraction. The myofibrillar pellet was resuspended in CP
buffer (10 mL/ g wet tissue), treated with collagenase 2 (30 mg/g wet tissue) and trypsin (5 mg/
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g wet tissue) for 10 minutes on ice with stirring, and homogenized at 1600 rpm with a tight-fit-
ting pestle (Potter-Elvehjem). An equal volume of CP2 buffer was added to the homogenate
and centrifuged for 10 min at 12,000 g. The pellet was resuspended in CP2 buffer (5 ml/g wet
tissue) and centrifuged for 10 min at 350 g. To isolate the IFM fraction, the supernatant was
collected by filtering through two layers of gauze and centrifuged at 7000 g for 20 min. Both
SSM and IFM fractions were washed first with 5 ml/g wet tissue of CP2 buffer and second with
2.5 ml/g wet tissue of KME buffer (BSA free). The KME buffer was used to resuspend the final
pellets to a concentration of ~30–40 mg mitochondrial protein/ml. Ice-cold conditions were
maintained throughout the SSM and IFM isolation procedure. The Lowry method was used to
determine mitochondrial protein concentration [24].
Oxidative phosphorylation
Oxygen consumption of SSM and IFM was measured with a Clark-type electrode (YSI model
53) in a final volume of 0.5 mL of respiration buffer [22, 26] at 30˚C in the presence of the fol-
lowing substrates and inhibitors: glutamate (G, 20 mM), pyruvate (P, 10 mM) plus malate (M,
5 mM), glutamate (G, 20 mM) plus malate (M, 5 mM), succinate (SR, 20 mM) plus rotenone
(7.5 μM), duroquinol (DHQR, 1 mM) plus rotenone (7.5 μM), N,N,N0,N0-tetramethyl-p-phe-
nylenediamine (TMPD, 1 mM) plus ascorbate (A, 10 mM) plus rotenone (TMPD+A)R,
7.5 μM, palmitoylcarnitine (PCN, 40μM) plus malate (M, 5 mM), palmitoyl-CoA (P-CoA,
20μM) plus malate (M, 5 mM) and plus carnitine (C, 5mM) assays. The concentrations of sub-
strates, inhibitor, uncoupler, and ADP refer to the final concentrations in the chamber. The
assays with complex II, III, and IV substrates were performed with rotenone to inhibit com-
plex I. ADP at a concentration of 0.1 mM was used to deplete endogenous substrates before
adding the substrates G, P+M, G+M, PCN+M or P-CoA+M+C, and 0.2 mM ADP (ADP-stim-
ulated) to measure State 3 respiration rate. For only S, DHQ, and TMPD+A assays ADP was
added to 0.1 mM (ADP-stimulated). After ADP depletion, State 4 respiration was measured
(ADP-limited). The mitochondria State 3 and 4 respiration rates were measured twice for each
assay. The respiration rate was then measured in the presence of high ADP concentration, 2
mM ADP. Finally, 0.2 mM of the uncoupler dinitrophenol (DNP) was added to the chamber
[25] to measure the oxidative capacity of mitochondria. The respiration rate is reported in
nAO min-1 mg-1 while the conversion factor to express the respiration rate in pmolO2 s
-1 mg-1
is 8.333.
Respiratory control ratios (RCR, State 3 divided by State 4) are calculated to quantify the
control of oxygen consumption by phosphorylation (‘coupling’). The concentration of ADP
was determined by an enzymatic method [21] and used to calculate the ADP/O ratio (ADP
mole added for mole of oxygen atom consumed), an index of the efficiency of oxidative phos-
phorylation [27].
Preparation of samples and enzymatic assays
Mitochondrial enzyme activities were measured as described previously [22, 26, 28, 29].
Briefly, fresh SSM and IFM (1 mg of mitochondrial protein) samples were treated with cholate
(10 mg cholate /mg of protein) [30] in 25 mM KPi/2mM EDTA buffer to a final volume of 1
mL supplemented with mammalian protease inhibitor cocktail (10 μL/ mg). The samples were
diluted 1:10 for the enzymatic assays. For cytochrome c oxidase (CIV) activity, 0.1 mg of fresh
intact mitochondria were suspended in 25 mM KPi/2mM EDTA buffer + protease inhibitor
and assayed with dodecyl D-maltoside in the cuvette with and without KCN; the first-order
rate constant was determined and the cyanide sensitive activity recorded. ETC enzyme activi-
ties were measured by specific donor–acceptor oxidoreductase activities in 0.1 M phosphate
Bioenergetics in insulin-resistant muscle mitochondria
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buffer using a spectrophotometer: CI, complex I–rotenone-sensitive; CIII, complex III—anti-
mycin A-sensitive; NCR, rotenone-sensitive NADH-cytochrome c reductase; SCR, antimycin
A-sensitive succinate-cytochrome c reductase; CS, citrate synthase; NFR, NADH-ferricyanide
reductase; SDH, succinate dehydrogenase; Aconitase; CII, TTFA sensitive complex II; CII+Q,
TTFA sensitive complex II with exogenous coenzyme Q analogue. The donors and acceptors
span specific regions of the ETC [26, 28, 29]. The ETC activity components were determined
using biochemical kinetics principles. Cytochrome c oxidase activity also was determined by a
polarographic assay using the protocol for kidney [31] and heart [32] mitochondria.
Skeletal muscle tissue samples were used to determine citrate synthase (CS) and succinate
dehydrogenase (SDH) activity and were treated with cholate (10 mg cholate/10 mg) in 25 mM
KPi/2mM EDTA buffer to a final concentration of 10 mg wet weight tissue/mL supplemented
with mammalian protease inhibitor cocktail (10 μL/ mL). Citrate synthase activity and succi-
nate dehydrogenase were measured using the spectrophotometer at 412 and 600 nm, respec-
tively [26, 33]. Mitochondrial cytochrome contents (aa3, b, c1, c) were determined using the
method of Williams [34].
Statistical analysis
Results are reported as means ± standard deviation. Differences between control and diabetic
rats during the time course were compared by one-way analysis of variance. A difference of
P< 0.05 was considered significant.
Results
Animal model
The characteristics of the animal model are reported in Table 1. The body weight of diabetic
(GK) rats is significantly lower than that of control (W) rats at both 18 and 28 weeks. The body
weight of GK rats does not change from 18 to 28 weeks, while that of W rats significantly
increases by 24%. The GK rats are hyperinsulinemic and hyperglycemic at 18 and 28 weeks
(Table 1).
Skeletal muscle mitochondria
To quantify mitochondrial content in skeletal muscle, the enzyme activities of CS and SDH are
used as mitochondrial markers. At 18 weeks, both CS and SDH activity are 15–25% lower in
skeletal muscle of diabetic rats compared to controls, but no difference is observed between
those two groups at 28 weeks (Table 2). This suggests a lower mitochondrial content in skeletal
muscle of only diabetic rats at 18 weeks than that at 28 weeks. The specific activity of CS
and SDH in the isolated mitochondrial is similar in the two groups of rats at both ages. The
Table 1. Animal characteristics: Body weight, insulin and glucose concentration in blood.
Unit W GK W GK
18 wk 28 wk
Body weight [g] 474±47 350±23* 590±58 389±21#
Insulin [ng mL-1] 2.8±1.4 5.2±2.1* 2.4±2.1 5.1±1.4#
Glucose [mM] 6±1 16.5±2.3* 6.5±1.7 17.4±3#
(n = 6)
* (P<0.03) W-18wk vs. GK-18 wk;
# (P<0.03) W-28wk vs. GK-28 wk;
https://doi.org/10.1371/journal.pone.0183978.t001
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yield for SSM and IFM of diabetic rats is 20% lower than from control rats only at 18 weeks
(Table 2). These yields in GK and W groups are consistent with the lower CS and SDH activity
in GK versus W rats at 18 weeks.
Aconitase activity measures mitochondrial matrix oxidative stress. The aconitase specific
activity is similar in both populations of mitochondria from control and diabetic group of rats.
In control rats, aconitase activity is 30% higher at 28 wk than at 18 wk.
Oxidative phosphorylation
The rates of oxidative phosphorylation for SSM and IFM are measured at 18 and 28 weeks of
age in both GK and W rats (Table 3 and Figs 1–3). In both populations of mitochondrial, the
RCR of the W and GK group of rats in both age groups is higher than 15 when glutamate is
used as substrate. The RCR values indicate that both populations of mitochondrial are highly
coupled in the diabetic and control rats at both ages.
Subsarcolemmal mitochondria
In GK rats (Table 3) at 18 weeks, state 3 respiration rate measured with glutamate is statistically
reduced in comparison to the W rats (13.5%). With addition of either a saturating concentra-
tion of ADP or by the uncoupler, DNP, the difference is eliminated. In the presence of gluta-
mate and malate, the state 3 rate is not different (wk 18, W: 328±26 vs. GK: 300±25 nAO min-1
mg-1). In the presence of pyruvate and malate, the respiration rate with a non-saturated con-
centration of ADP is similar in both groups of rats (Fig 1a), while with a saturating concentra-
tion of ADP it is reduced in GK (Fig 2a). Substrates for complex II, III, and IV are used to
probe the respective entry points of reducing equivalents into the ETC. In the presence of
these substrates, state 3 respiration rate with an unsaturated or saturated concentration of
ADP is similar in GK and W rats. Only with a substrate for complex III (Fig 2c) the uncoupled
mitochondrial respiration rate in GK is statistically different from that of W rats. State 4
Table 2. Specific activities of mitochondrial enzymes in skeletal muscle homogenate (U g-1 wet weight) and isolated subsarcolemmal (SSM) and
interfibrillar (IFM) mitochondria (U g-1 mitochondrial protein).
Unit W GK W GK
18 wk 28 wk
Skeletal muscle homogenate
Citrate Synthase [U g-1] 40±6 33±3* 35.5±3 39.6±6
Succinate Dehydrogenase [U g-1] 3.2±0.3 2.4±0.3* 3.8±0.5 3.9±0.6
Isolated mitochondria
Citrate Synthase SSM [U g-1] 1714±143 1658±112 1753±163 1646±303
IFM [U g-1] 1915±140 1929±272 2088±234 2208±65
Succinate Dehydrogenase SSM [U g-1] 224±24 220±27 232±20 206±35
IFM [U g-1] 242±21 254±46 275±18 288±32
Aconitase SSM [U g-1] 579±196 627±53 690±71 600±86
IFM [U g-1] 593±105 695±75 826±99¥ 750±93
Mitochondrial Yield
SSM [mg g-1] 3.5±0.4 2.8±0.3* 3.1±0.6 2.8±0.4
IFM [mg g-1] 8.7±1.4 7.0±0.9* 6.9±1¥ 6.5±1
(n = 6)
* (P<0.05) W-18wk vs. GK-18 wk;
¥ (P<0.05) W-18wk vs. W-28 wk;
https://doi.org/10.1371/journal.pone.0183978.t002
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respiration rate measured for different substrate complexes of the ETC is similar in GK and
control rats. For the same substrate, RCR is similar in GK and W rats except for a trivial differ-
ence for succinate and duroquinol (S1 Fig).
In GK rats at 28 weeks, the respiration rates for glutamate (Table 3) and for pyruvate
+malate (Fig 1a) are similar to those of the control rats. In the diabetic group, state 3 respira-
tion rate for complex II, III, and IV substrates with non-saturated or saturated concentrations
of ADP are lower (20–25%) than those of the control group (Figs 1a and 2a). Uncoupled oxida-
tive capacity with complex II and III substrates is similar in GK and control rats, whereas with
complex IV the rate is lower in GK compared to the control (Fig 2c).
State 4 respiration rate (Fig 1c and 1d) is similar between controls and diabetic rats except
that with (TMPD+A)R substrate the respiration rate in diabetic SSM is lower than control
group without any change in RCR. Also, state 4 respiration rate increases for complex III sub-
strate from 18 to 28 weeks in diabetic rats with a small change in RCR.
Interfibrillar mitochondria
In both age groups, the state 3 respiration rate measured with glutamate (Table 3), pyruvate +
malate, or substrates for complex II, III, and IV is not different between diabetic and control
rats (Fig 1b). Additionally, the respiration rate obtained with a saturated concentration of
ADP or by DNP is not altered in diabetic rats at 18 and 28 weeks (Fig 2b and 2d). In diabetic
rats, state 4 respiration rates for complex I and III substrates increase from 18 to 28 weeks (Fig
1d), but with no differences between diabetic and control rats.
The ADP/O ratios determined for complexes I, II, and III substrates are similar in diabetic
and control rats in both populations of mitochondria at 18 and 28 weeks (S2 Fig). In the pro-
gression from 18 to 28 weeks, the ADP/O ratio slightly decreases in both mitochondrial popu-
lations in GK with complex I and III substrates.
Table 3. Oxidative phosphorylation using glutamate in skeletal muscle subsarcolemmal mitochondria (SSM) and interfibrillar mitochondria (IFM)
in control (W) and diabetic (GK) rats.
Unit W GK W GK
18 wk 28 wk
SSM
State 3 [nAO min-1 mg-1] 297±22 257±26* 305±22 279±22
State 4 [nAO min-1 mg-1] 14±5.5 12.7±4.4 12.6±4 17.3±6
RCR [-] 26.5±16.1 21.9±5 27±10 18.0±5.6
ADP/O [-] 2.96±0.2 2.90±0.21 2.88±0.17 2.70±0.14
Maximal ADP [nAO min-1 mg-1] 409±31 380±48 384±56 361±31
DNP [nAO min-1 mg-1] 446±35§ 421±63§ 439±66§ 407±34§
IFM
State 3 [nAO min-1mg-1] 365±27 339±39 356±37 363±36
State 4 [nAO min-1mg-1] 18.6±4.7 22.4±6.3 15.4±10 18.9±4.6
RCR [-] 21.5±7.5 16.3±5.4 30.7±15.7 20.7±5.7
ADP/O [-] 2.99±0.11 3.04±0.26 2.84±0.25 2.8±0.13
Maximal ADP [nAO min-1mg-1] 550±47 509±71 467±65 528±55
DNP [nAO min-1mg-1] 602±55§ 573±57§ 535±94§ 608±24§
The respiratory rate is normalized to mg of mitochondrial protein.
* (P<0.05) W-18wk vs. GK-18 (n = 6)
§ (P<0.02) Maximal ADP vs. DNP (n = 6)
https://doi.org/10.1371/journal.pone.0183978.t003
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Fatty acid oxidation
Mitochondrial fatty acid oxidation was measured in presence of CPT1-dependent (palmitoyl-
CoA) and independent (palmitoylcarnitine) substrates. In particular, the enzyme, CPT1, cata-
lyzes palmitoyl-CoA conversion on the outer membrane of mitochondria in the presence of
carnitine and the resulting palmitoylcarnitine is transported into mitochondria via carnitine-
acylcarnitine translocase. Therefore, oxidative phosphorylation rates measured in the presence
of palmitoyl-CoA and palmitoylcarnitine provide information on CPT1 and mitochondrial
oxidation of fatty acids. In SSM, fatty acid oxidation in the presence of palmitoylcarnitine or
palmitoyl-CoA is similar in diabetic and control rats at 18 and 28 weeks (Fig 3). In IFM, fatty
acid oxidation in the presence of palmitoylcarnitine is similar in both rat groups at 18 and 28
weeks while that in the presence of palmitoyl-CoA reveals differences between GK and W rats.
At 18 wk, palmitoyl-CoA oxidation is similar in both diabetic and control groups, whereas the
oxidation rate increases by 25% from 18 to 28 weeks in IFM from diabetic rats; oxidation does
not change in control rats during this period (Fig 3b and 3d). Thus, this adaptation results in a
Fig 1. State 3 (a and b) and state 4 (c and d) respiration rates of skeletal muscle SSM and IFM at 18 and 28 weeks. (Control (W) and
diabetic (GK) groups are designated with open and grey bars, respectively). Complex I substrate (malate and pyruvate, P); Complex II
(succinate and rotenone, SR); Complex III (duroquinol and rotenone, DHQR); Complex IV (TMPD, ascorbate and rotenone, (TMPD+A)R.
¥(P<0.05) W-18wk vs. W-28; ¶(P<0.05) GK-18wk vs. GK-28; #(P<0.05) control W-28wk vs. diabetic GK-28; (n = 6), Mean ± SD.
https://doi.org/10.1371/journal.pone.0183978.g001
Bioenergetics in insulin-resistant muscle mitochondria
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respiration rate 30–35% higher in GK rats than that in the control group at 28 weeks and
approaches the oxidation rate of palmitoylcarnitine.
Electron transport chain and cytochrome assays
The SSM and IFM function of the ETC complexes is evaluated with specific assays that quan-
tify the activity of the ETC components. The activity of the ETC components in SSM and IFM
of diabetic rats are similar to those of the control (Fig 4) group for both age groups. In SSM
and IFM, the activity measured for a) rotenone-sensitive CI; b) linked complex I and III
(NCR), c) flavin protein domain of complex I (NFR); d) linked complex II and III (SCR) in
GK is similar to that observed in controls. In SSM, complex II activity with endogenous coen-
zyme Q (CoQ) is unaffected, whereas at 28 weeks a minor decrease in activity is observed
when exogenous CoQ is added (Fig 4). In IFM, complex II activity with endogenous or exoge-
nous CoQ is unaffected at 18 and 28 weeks. In SSM and IFM, complex III activity is similar in
GK and controls at both 18 and 28 weeks; however, in SSM from GK rats there is an aging
Fig 2. ADP saturated concentration (a and b) and uncoupled (c and d) respiration rates of skeletal muscle SSM and IFM at 18 and 28
weeks. Notation as in Fig 1. Complex I substrate (malate and pyruvate, P); Complex II (succinate and rotenone, SR); Complex III (duroquinol
and rotenone, DHQR); Complex IV (TMPD, ascorbate and rotenone, (TMPD+A)R. *(P<0.05) W-18wk vs. GK-18 (n = 6); #(P<0.05) W-28wk vs.
GK-28; (n = 6), Mean ± SD.
https://doi.org/10.1371/journal.pone.0183978.g002
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effect with a decrease at 28 weeks relative to that at 18 weeks. We do not consider as physiolog-
ically relevant the differences observed for complex II and III activities because the linked
activities of complex I and III (Fig 4, NCR) and of complex II and III (Fig 4, SCR) are unaf-
fected in diabetic rats.
In the control group, cytochromes aa3, b, and c1 content in SSM are similar to IFM (Fig 5),
while cytochrome c is higher in IFM than SSM. In the SSM of both control and diabetic rats,
the content of most of the cytochromes is similar with age except for cytochrome c, where only
in the control group, there is a significant increase (26%) from 18 to 28 weeks. At 28 weeks,
cytochrome aa3, b, and c content in SSM of GK rats is significantly lower than that of the con-
trol rats. In the IFM population at 18 weeks, no differences are observed between diabetic and
control groups for any cytochromes. At 28 weeks, cytochrome aa3, and c1 are not different.
Cytochrome b and c content increases significantly by 32% and 21% in the control group and
by 10% and 16% in diabetic rats between 18 and 28 weeks, respectively.
The first order rate constant of complex IV measured in solubilized mitochondria (Fig 4) is
not different between GK and control rats, but in both coupled or uncoupled SSM the
Fig 3. ADP unsaturated (a and b) and saturated concentration (c and d) respiratory rates of lipid substrates in skeletal muscle
SSM and IFM at 18 and 28 weeks. Notation as in Fig 1. Malate and palmitoylcarnitine, PCN; malate, palmitoyl-CoA and carnitine (P-CoA
+C). ¶(P<0.05) GK-18wk vs. GK-28; #(P<0.05) W-28wk vs. GK-28; (n = 6), Mean ± SD.
https://doi.org/10.1371/journal.pone.0183978.g003
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oxidation rate in the presence of complex IV substrate is reduced in GK rats. To reconcile this
apparent discrepancy a polarographic assay of azide-sensitive cytochrome c oxidase was per-
formed in permeabilized SSM with endogenous cytochrome c (Fig 6). The assay reveals no dif-
ferences between GK and W rats. With the addition of exogenous cytochrome c, the activity in
both GK and W SSM increases about 2.5 fold; however, a statistically significant decrease of
30% activity is observed in GK rats compared to controls.
Discussion
An integrated approach that combines oxidative phosphorylation, electron transport chain activ-
ity, and biochemical measurements was used to evaluate bioenergetic function in mitochondrial
populations of insulin-resistant skeletal muscle from non-obese rats. This approach provided
large representative samples of both SSM and IFM populations with a high recovery and high
quality from both groups of rats. There were minor defects in oxidative phosphorylation only in
Fig 4. The enzymes activity of ETC of isolated skeletal SSM and IFM at 18 and 28 weeks. Notation as in Fig 1. Rotenone-sensitive NADH-
cytochrome c reductase (NCR); NADH ferricyanide reductase (NFR); Antimycin A-sensitive succinate-cytochrome c reductase (SCR); Complex II
activity (CII); total complex II with exogenous coenzyme Q (CII+Q); Complex III (CIII); Complex IV (CIV). ¥(P<0.05) W-18wk vs. W-28; ¶(P<0.05) GK-
18wk vs. GK-28; #(P<0.05) W-28wk vs. GK-28; (n = 6), Mean ± SD.
https://doi.org/10.1371/journal.pone.0183978.g004
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SSM while IFM function was preserved. In SSM at 18 weeks, mitochondria dysfunction was con-
fined to a minimally reduced oxidative phosphorylation rate with glutamate, but was normal
with a saturated concentration of ADP or in the presence of other substrates of the ETC. In SSM
at 28 weeks, the oxidative phosphorylation rate was slightly reduced in the presence of complex
II, III, and IV substrates, but is considered unimportant because of the absence of defects
upstream as we found with polarographic and spectrophometric assays. Thus, these small devia-
tions do not affect overall SSM bioenergetic function of the diabetic rats. Fatty acid oxidation is
unaltered in SSM and IFM at both ages, and palmitoyl-coA oxidation was even enhanced in
IFM GK at 28 weeks. These data provide compelling evidence that mitochondrial function is not
affected in insulin-resistant skeletal muscle from T2DM non-obese rats.
Our study follows a previous study on the metabolic function of skeletal muscle mitochon-
dria of GK rats evaluated using 31P MRS and BOLD MRI [35]. The selfsame GK and control
rats used to study mitochondria function in vivo [35] were used in this work to study mito-
chondria in vitro. The mitochondrial function in skeletal muscle of GK rats was normal at 12
and 20 weeks and is consistent with our study supporting the absence of impairment in the
bioenergetic function of the subpopulations of mitochondria.
The GK rat is a well-characterized non-obese model of T2DM that exhibits spontaneous
moderate hyperglycemia and peripheral and hepatic insulin-resistant hyperinsulinemia
[36,37] without abnormal elevated content of lipids in blood. In our work, the hyperglycemia
and hyperinsulimeia observed in the GK rats at 18 and 28 weeks confirmed the metabolic
characteristics of this T2DM model observed in previous work [37, 38, 39].
Mitochondrial content
A reduced mitochondria content in GK rats was observed only at 18 weeks, while there was no
difference between the two groups of rats at 28 weeks. A lower content of SDH in GK com-
pared to controls was previously reported [40]. The animals in the control group continue to
grow between 18 to 28 weeks of age while GK rats do not. Consistent with this result, a GK
Fig 5. The cytochrome content in isolated skeletal SSM and IFM at 18 and 28 weeks. Notation as in Fig 1. ¥(P<0.05) W-18wk vs. W-28; ¶(P<0.05)
GK-18wk vs. GK-28; #(P<0.05) W-28wk vs. GK-28; (n = 6), Mean ± SD.
https://doi.org/10.1371/journal.pone.0183978.g005
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study [41] reported reduced skeletal muscle mass and alteration of muscle fiber distribution,
e.g., type I and II, in GK rats. Thus, a skeletal muscle fiber shift from one fiber type to another
could be related to the effects observed in the rats at 28 weeks.
Subsarcolemmal mitochondria
In the presence of glutamate, SSM from GK rat had a lower state 3 respiration rate than that of
the control group (Table 3). Oxidative phosphorylation in the presence of glutamate provided
information not only on the phosphorylation process, but also on glutamate transport and
glutamate dehydrogenase; that in the presence of pyruvate and malate reflects the monocar-
boxylate and dicarboxylate transporters as well as pyruvate and malate dehydrogenase. The
difference between GK and W observed in state 3 respiration in the presence of glutamate
Fig 6. Polarographic cytochrome c oxidase assay of skeletal muscle SSM at 28 weeks. Notation as in Fig 1. #(P<0.05) W-28wk
vs. GK-28; (n = 5), Mean ± SD.
https://doi.org/10.1371/journal.pone.0183978.g006
Bioenergetics in insulin-resistant muscle mitochondria
PLOS ONE | https://doi.org/10.1371/journal.pone.0183978 August 29, 2017 13 / 19
should not be ascribed to a defect in complex I because it vanished when a saturated concen-
tration of ADP is used to stimulate oxidative phosphorylation.
The SSM defect observed could be related to the ATP synthase, the adenine nucleotide
translocase (ANT) and/or inorganic phosphate transporter. ANT is responsible for ADP/ATP
exchange across the mitochondrial inner membrane, while the phosphate transporter provides
for the movement of inorganic phosphate into mitochondria. Thus, a reduced respiration rate
could be related to a low affinity of ANT for the substrate, but this does not appear to be the
case because in our study, the respiration rate with an unsaturated concentration of ADP was
not reduced for P+M, G+M, or P-CN. Alternatively, the difference between the two groups
could be related to glutamate transporter or glutamate dehydrogenase activity, but this possi-
bility is eliminated because oxidative phosphorylation at saturated concentration of ADP and
uncouple respiration rate are unaffected. The difference between GK and W in state 3 respira-
tion rate was eliminated in the presence of glutamate and malate; glutamate is metabolized by
aspartate aminotransferase and malate by malate dehydrogenase.
The analysis of the respiration rate in the two populations of mitochondria revealed a spe-
cific alteration of the oxidative phosphorylation using substrates for complex II, III, and IV
(Figs 2 and 3) only in skeletal muscle SSM of the older GK rats. By the addition of an uncou-
pler, this defect was relieved when using substrates for complex II and III but was still present
using complex IV substrate. The lack of effect on oxidation starting at complex II and III sug-
gests that complex IV does not affect upstream substrates and is physiological irrelevant. The
components of the ETC work as units in series with electrons entering in complex I, II and III
sites that share the same common path to reach complex IV to reduce oxygen and produce
water. Thus, complex IV is located upstream of the ETC and it can control the amount of elec-
trons flowing from complex I to IV per unit of time. In our study, complex I was inhibited
with rotenone to evaluate the function of the other complexes. The defect in Complex IV does
not limit the electron flux and thus, the respiration rate in presence of complex II or III sub-
strates because the uncoupled mitochondria respiration rate measured in GK rats with com-
plex II or III substrates was similar to that observed in the control group. Furthermore,
complex V could be responsible for the respiration difference observed for complex II and III
substrates. Under these conditions, the oxidative phosphorylation rates were reduced by 20–
25% in comparison to the control group. Although the effect of these mitochondrial alterations
on the skeletal muscle remains to be determined, they should not have a major effect on energy
metabolism. Indeed, two independent NMR studies reported that mitochondria ATP produc-
tion was not altered in re-perfused [35] or contracting [42] skeletal muscle at 18 and 28 weeks
old GK rats, respectively.
Alternative mechanisms related to a decrease in mitochondrial cytochromes could explain
the age-dependent defects in oxidative phosphorylation observed in GK rats at 28 weeks. At
this age, significant decreases (50%, 40%, and 16%) were observed in cytochrome aa3, b, and c
in SSM of GK rats compared to the control group. To determine whether cytochrome c was
responsible for the defect, a polarographic assay of complex IV with and without exogenous
cytochrome c was performed. The addition of exogenous cytochrome c did not correct the
defect in the polarographic activity of cytochrome c oxidase. This indicates that beside the
reduced amount of cytochrome c, other factors are responsible for the observed defect.
Cytochrome b also was lower than that of the control group (Fig 5). The total cytochrome b
content is distributed between complexes II and III within the mitochondria [43]. Neverthe-
less, the reduced cytochrome b content in SSM does not affect complex II or III function
because the state 3 respiration rate observed for complex II or III substrate was relieved by the
addition of the uncoupler (Fig 2a and 2c). Moreover, the activity of complex II and III was
unaffected in GK rats (Fig 4). The decrease of the transmembrane protein, cytochrome aa3,
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which is a subunit of complex IV, is not responsible for the defect observed in SSM of GK rats
(Fig 5), because the complex IV assay does not reveal any enzyme activity difference between
GK and W rats (Fig 4). It should be noted that the differences between GK and W rats in oxi-
dative phosphorylation rate in the presence of complex IV (Fig 2a and 2c) and endogenous
cytochrome c substrates disappear when the mitochondrial membrane is disrupted (Fig 6).
This indicates a potential aging effect (from 18 to 28 weeks) leading to a structural defect of the
inner mitochondria membrane. A selective aging effect on heart mitochondrial dysfunction
was previously reported and attributed to an altered membrane environment, rather than to a
reduced protein subunit content [32].
In conclusion, the complex IV defect is not considered relevant because it does not affect
the respiration rate obtained with C-II and III substrates and the complex IV enzyme activity
assay does not reveal any difference between GK and W rats.
Interfibrillar mitochondria
The IFM function was normal in GK rats at both age groups. The bioenergetic assays per-
formed to probe the function of the ETC components showed no difference between GK and
controls (Figs 1 and 2). In addition, the biochemical assays to quantify the activity of com-
plexes of the ETC showed no difference between GK and controls (Fig 4). This evidence was
consistent with the absence of difference in state 3 respiration rate measured in presence of
an unsaturated or saturated concentration of ADP and in uncoupled mitochondria (Figs 1
and 2).
Fatty acid oxidation
Both transport and utilization of fat in myocytes contribute to lipid accumulation. Previous
studies presented conflicting results on mitochondrial dysfunction as a key factor in impairment
of fatty acid utilization in skeletal muscle cells [4, 7, 8, 44]. Some obese and insulin resistant
human and animal studies provided evidence in support of enhanced fatty acid transport [45,
46]. A bioenergetics study on permeabilized skeletal muscle fiber reported on even higher oxida-
tive phosphorylation rate using palmitoylcarnitine in GK rats [38] compared to the control
group but similar ADP/O. In that study palmitoylcarnitine respiration rate decreased 5% from 6
to 16 weeks. Thus, the difference between this and our study possibly is related to the GK age.
In our study, the higher respiration rate with palmitoyl-CoA substrate in IFM of GK rats
than that obtained for the control group was not related to differences in respiratory capacity
of the ETC or mitochondria content since ETC components and CS activities were similar in
the two groups. Also, the difference between GK and W rats should not be attributed to an
effect of palmitoyl-CoA on ANT, since the palmitoyl-CoA oxidation rate difference between
GK and W also was observed with a saturated concentration of ADP (Fig 5). In this condition,
the effect of palmitoyl-CoA inhibition on ANT transferase, which is responsible for export/
import of ATP/ADP from/to the mitochondrial matrix, is negligible. The difference in palmi-
toyl-CoA oxidation between the two groups of rats could be related to a higher CPT1 activity
in IFM of GK rats than that in IFM of Wistar rats. Although these results are in agreement
with enhanced FA transport in obese Zucker rats, the skeletal muscle adaptations appear dif-
ferent between obese and non-obese rats during the development of the disease. While obesity
appears to enhance FA transport and oxidation predominately in SSM by an increase of FAT/
CD36, CS, and β-hydroxyacyl-CoA dehydrogenase activities with unaltered CPT1 [19], the
absence of obesity and presence of T2DM lead to enhancement of FA oxidation only in IFM
by CPT-I. It is possible that the enhanced ability to metabolize fatty acid is related to a com-
pensatory skeletal muscle adaptation to the reduced utilization of carbohydrate fuel due to
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insulin resistance. In T2DM patients and obese insulin-resistant skeletal muscle, CPT-I activity
was reduced [47]. The effects of obesity on skeletal muscle metabolic function were also inves-
tigated in human subjects [12]. Obesity was found to not alter FA transport and oxidation,
while impairment of mitochondrial function was attributed mainly to a reduced content of
these organelles.
Mitochondria efficiency
The ADP/O ratio provides information on oxidative phosphorylation efficiency. The ADP/O
ratio is similar in both groups of rats although there is an age effect with a significant decrease
of the ratio of both SSM and IFM from 18 to 28 weeks only for GK rats. In human skeletal
muscle, the mitochondrial ADP/O ratio of T2DM patients was not different from that of the
control group although there was a trend for less efficient mitochondria in the diabetic group
[10]. Animal studies showed that skeletal muscle adaptations to obesity are accompanied by an
increase of oxidative phosphorylation efficiency [48, 49] that potentially can contribute to the
development of insulin resistance induced by a high fat diet [50]. Thus, our study showed a dif-
ferent mitochondrial adaptation to IR in the absence of obesity in comparison to that occur-
ring in obesity.
In conclusion, in the absence of chronic tissue fat overload, the bioenergetic function of
both mitochondrial populations of insulin-resistant skeletal muscle is not compromised. Mito-
chondrial function is normal in T2DM in the absence of a fat overload during the progression
of the disease. Thus, increased fuel load rather than mitochondrial oxidative capacity is the
trigger event altering insulin action in T2DM [4].
Supporting information
S1 Fig. Respiratory control ratio (RCR) of skeletal muscle SSM (a) and IFM (b) at 18 and
28 weeks. Notation as in Fig 1. Complex I substrate (malate and pyruvate, P); Complex II (suc-
cinate and rotenone, SR); Complex III (duroquinol and rotenone, DHQR).
¥(P<0.05) W-18wk
vs. W-28; ¶(P<0.05) GK-18wk vs. GK-28; (P<0.05) W-18wk vs. GK-18 (n = 6); #(P<0.05)
control W-28wk vs. diabetic GK-28; (n = 6), Mean ± SD.
(TIF)
S2 Fig. ADP to atomic oxygen phosphorylation ratio ADP/O of skeletal muscle SSM (a)
and IFM (b) at 18 and 28 weeks. Notation as in Fig 1. Complex I substrate (malate and pyru-
vate, P); Complex II (succinate and rotenone, SR); Complex III (duroquinol and rotenone,
DHQR).
¶(P<0.05) GK-18wk vs. GK-28; (n = 6), Mean ± SD.
(TIF)
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